1. Editorial – Intramembrane receptor–receptor interactions and volume transmission

   • Staffan Cullheim

   EditorialNotes Pages: 1 - 2

2. The brain as a system of nested but partially overlapping networks. Heuristic relevance of the model for brain physiology and pathology

   • L. F. Agnati
   • D. Guidolin
   • K. Fuxe

   OriginalPaper 17 August 2006 Pages: 3 - 19

3. Aβ peptides as one of the crucial volume transmission signals in the trophic units and their interactions with homocysteine. Physiological implications and relevance for Alzheimer’s disease

   • L. F. Agnati
   • S. Genedani
   • K. Fuxe

   OriginalPaper 14 September 2006 Pages: 21 - 31

4. Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?

   • H.-Q. Wu
   • A. Rassoulpour
   • R. Schwarcz

   OriginalPaper 24 August 2006 Pages: 33 - 41

5. Environmental enrichment reduces the function of D1 dopamine receptors in the prefrontal cortex of the rat

   • A. Del Arco
   • G. Segovia
   • F. Mora

   OriginalPaper 12 September 2006 Pages: 43 - 48

6. Intramembrane receptor–receptor interactions: a novel principle in molecular medicine

   • K. Fuxe
   • M. Canals
   • L. F. Agnati

   OriginalPaper 27 October 2006 Pages: 49 - 75

7. A boolean network modelling of receptor mosaics relevance of topology and cooperativity

   • L. F. Agnati
   • D. Guidolin
   • K. Fuxe

   OriginalPaper 12 September 2006 Pages: 77 - 92

8. Receptor–receptor interactions involving adenosine A₁ or dopamine D₁ receptors and accessory proteins

   • R. Franco
   • C. Lluis
   • K. Fuxe

   OriginalPaper 06 October 2006 Pages: 93 - 104

9. Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D₂ interactions in the basal ganglia

   • T. Antonelli
   • M. C. Tomasini
   • L. Ferraro

   OriginalPaper 19 September 2006 Pages: 105 - 113

10. Receptor–receptor interactions in central cardiovascular regulation. Focus on neuropeptide/α₂-adrenoreceptor interactions in the nucleus tractus solitarius

    • Z. Díaz-Cabiale
    • C. Parrado
    • J. A. Narváez

    OriginalPaper 21 September 2006 Pages: 115 - 125

11. A history of dopamine agonists. From the physiology and pharmacology of dopamine to therapies for prolactinomas and Parkinson’s disease – a subjective view

    • R. Horowski

    OriginalPaper 10 August 2006 Pages: 127 - 134

12. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms

    • G. Mudo
    • N. Belluardo
    • K. Fuxe

    OriginalPaper 17 August 2006 Pages: 135 - 147